Potentiation of fibrinolytic therapy in acute myocardial infarction: expanding the role of ACE-inhibitors
Andreotti, F.; Biondi-Zoccai, G.G.L.
Thrombosis and Haemostasis 88(2): 176-178
2002
ISSN/ISBN: 0340-6245 PMID: 12195684 Document Number: 549488
Document emailed within 1 workday
Related Documents
Pinelli, G.; Urbinati, S. 2001: Bolus fibrinolytic therapy in acute myocardial infarction Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(12): 1360-1362Davies, C.; Christenson, J.; Campbell, A.; Cox, J.L.; Huynh, T.; Matheson, S.; Daly, P.A.; Hilbe, J. 2004: Fibrinolytic therapy in acute myocardial infarction: time to treatment in Canada Canadian Journal of Cardiology 20(8): 801-805
Purcell, H.; Coats, A.; Fox, K.; Campbell, R. 1995: Improving outcome after acute myocardial infarction: what is the role of ACE inhibitors? British Journal of Clinical Practice 49(4): 195-199
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
Ottani, F.; Bresciani, B.; La Vecchia, L.; Favero, L.; Fontanelli, A.; Galvani, M. 2002: Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 3(5): 544-554
Kleber, F.X.; Reindl, I.; Wenzel, M.; Rodewyk, P.; Beil, S.; Kosloswki, B.; Doering, W.; Sabin, G.V.; Hinzmann, S.; Winter, U.J. 1993: Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE) Herz 18(Suppl 1): 424-429
Dorney, E. 1981: The role of pacemaker therapy in acute myocardial infarction Primary Care 8(3): 509-517
Courbier, R.; Jausseran, J.M.; Forlot, P.; Torresani, J.; Henry, E.; Jouve, A. 1971: Blood fibrinolytic potential during acute myocardial infarction La Presse Medicale 79(41): 1789-1792
Gogna, A.; Agarwal, A.K.; Singh, C.P. 1994: Role of routine magnesium therapy in acute myocardial infarction Journal of the Association of Physicians of India 42(1): 49-51
Iglesias, M.L.; Pedro-Botet, J.; Hernández, E.; Solsona, J.F.; Molina, L.; Alvarez, A.; Auguet, T. 1996: Fibrinolytic treatment in acute myocardial infarction: analysis of delay Medicina Clinica 106(8): 281-284
Joseph, A.; Talley, J.D.; Kupersmith, J. 1988: Acute intervention in myocardial infarction--role of thrombolytic therapy and adjuvant angioplasty Journal of the Kentucky Medical Association 86(10): 561-566
Mittal, M.M.; Gupta, N.N.; Mehrotra, R.M. 1970: A study of plasma fibrinogen content and its fibrinolytic activity following acute myocardial infarction Journal of the Association of Physicians of India 18(10): 795-801
Nielsen, J.D. 1988: Fibrinolytic treatment in acute myocardial infarction. Results of randomized studies in recent years Ugeskrift for Laeger 150(30): 1831-1836
Somelofski, C.A.; Osguthorpe, S. 1991: Early hospital arrival and treatment of patients with acute myocardial infarction: practice management and your role in thrombolytic therapy. Introduction Heart and Lung: the Journal of Critical Care 20(5 Pt 2): 535-537
Fornaro, G.; Lazzero, M.; Giacalone, A.; Aralda, D.; Prando, M.Domenica.; Rossi, L.; Bongo, A.Sante. 2008: Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death Giornale Italiano di Cardiologia 9(6): 408-420
Wagner, S.; Schneider, S.; Schiele, R.; Fischer, F.; Dehn, H.; Grube, R.; Becker, G.; Baumgärtel, B.; Altmann, E.; Senges, J. 1999: Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany Zeitschrift für Kardiologie 88(10): 857-867
Bordalo-Sá, A.L.; Ferreira, D.; Tuna, J.L.; Longo, A.; Correia, M.J.; Diogo, A.N.; Gaspar, F.; Ribeiro, C.; Soares-Costa, J.T. 1999: The variability of the heart rate in the first 24 hours after fibrinolytic therapy in acute myocardial infarct Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(3): 261-265
Preobrazhenskiĭ, D.V.; Sidorenko, B.A.; Pershukov, I.V.; Batyraliev, T.A.; Pataraia, S.A. 2006: Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril Kardiologiia 46(5): 89-95
Lavi, S.; Gruberg, L.; Kapeliovich, M.; Hammerman, H.; Boulos, M.; Grenadier, E.; Aronson, D.; Markiewicz, W.; Beyar, R. 2005: The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients Journal of Invasive Cardiology 17(6): 296-299
Yoshida, S.; Miura, T.; Matsuki, T.; Iimura, K. 1985: Recent trends in the management of myocardial infarct--drug therapy of acute myocardial infarction Hokkaido Journal of Medical Science 60(6): 801-805